Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Leases (2022 - 2025)

Biodesix's Current Leases history spans 4 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Current Leases rose 89.71% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 89.71%, while the annual FY2025 figure was $1.4 million, 89.71% up from the prior year.
  • Current Leases reached $1.4 million in Q4 2025 per BDSX's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.8 million in Q1 2023 to a low of $252000.0 in Q4 2023.
  • Average Current Leases over 4 years is $1.1 million, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Current Leases: plummeted 84.56% in 2024, then surged 310.67% in 2025.
  • A 4-year view of Current Leases shows it stood at $1.5 million in 2022, then plummeted by 83.67% to $252000.0 in 2023, then soared by 185.32% to $719000.0 in 2024, then skyrocketed by 89.71% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Current Leases are $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.2 million (Q2 2025).